Generation Bio Investor Relations Material

Generation Bio Co. is a biotechnology company focused on the development of genetic medicines to treat both rare and prevalent diseases. Leveraging its proprietary platform, the company is working on a range of therapies aimed at addressing conditions affecting the liver, retina, skeletal muscle, central nervous system, and oncology. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the Nasdaq.